Skip to content

A Study to Compare Analyte Levels in Blood Samples Collected Using the TAP20-C Device With Results Obtained by Fingerstick

A Study to Compare Analyte Levels in Blood Samples Collected Using the TAP20-C Device With Results Obtained by Fingerstick

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02045758
Enrollment
120
Registered
2014-01-27
Start date
2014-12-31
Completion date
2015-09-30
Last updated
2014-09-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Brief summary

This study will compare blood collection from the forearm using an investigational device TAP20-C to blood collection from the fingertip.

Interventions

DEVICETAP20-C

Sponsors

Seventh Sense Biosystems
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Healthy Subject Group 1. Male and female volunteers 18 years of age or older. 2. Voluntary written consent to participate in this study. Diabetic Subject Group <!-- --> 1. Male and female volunteers 18 years of age or older. 2. Have been diagnosed with Type 1 or Type 2 diabetes mellitus by self-report. 3. Voluntary written consent to participate in this study.

Exclusion criteria

1. Subjects who are pregnant or nursing mothers by self-report. 2. Subjects with a history of skin disorders or who present with abnormal skin integrity or atypical skin health within the areas to be tested. 3. Subjects with a missing index or middle finger on either hand or a missing forearm 4. Subjects who have known allergies to titanium.

Design outcomes

Primary

MeasureTime frameDescription
Non-Inferiority of Analyte LevelsDay 1The study will compare the concentrations of various analytes in blood samples collected by both collection methods in a single 2 hour session.

Countries

United States

Contacts

Primary ContactHoward Bernstein, MD, Phd
hbernstein@7sbio.com617-547-7246

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026